Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
-
* Corresponding author: Robert W Shafer rshafer@stanford.edu
Retrovirology 2008, 5:74 doi:10.1186/1742-4690-5-74
Accesses
- Last 30 days: 73 accesses
- Last year: 880 accesses
- All time: 4466 accesses
Cited by
BioMed Central: 3 citations
|
Research
Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase Mohd J Dar, Blandine Monel, Lavanya Krishnan, Ming-Chieh Shun, Francesca Di Nunzio, Dag E Helland, Alan Engelman Retrovirology 2009, 6:94 (19 October 2009) |
|
Review
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors Erik Serrao, Srinivas Odde, Kavya Ramkumar, Nouri Neamati Retrovirology 2009, 6:25 (5 March 2009) |
|
Correspondence
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure Sebastiaan J van Hal, Belinda Herring, Zaquan Deris, Bin Wang, Nitin K Saksena, Dominic E Dwyer Retrovirology 2009, 6:12 (9 February 2009) |